US Patent Issued to Deutsches Krebsforschungszentrum, Bayer Pharma, Bayer on Nov. 25 for "Substituted aminoquinolones as dgkalpha inhibitors for immune activation" (German, Swiss Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,478,621, issued on Nov. 25, was assigned to Deutsches Krebsforschungszentrum (Germany), Bayer Pharma AG (Germany) and Bayer AG (Germany).

"Substituted aminoquinolones as dgkalpha inhibitors for immune activation" was invented by Norbert Schmees (Berlin), Lars Wortmann (Biberbach an der RiB, Germany), Dennis Kirchhoff (Berlin), Thi Thanh Uyen Nguyen (Berlin), Nicolas Werbeck (Freiburg, Germany), Ulf Bomer (Glienicke, Germany), Kirstin Petersen (Berlin), Christina Kober (Lollar, Germany), Detlef Stockigt (Potsdam, Germany), Christian Lechner (Berlin), Robin Michael Meier (Wain, Germany), Simon Anthony Herbert (Berlin), Isabel Patrizia Kerschgens (Zurich, Switzerland), Dirk Kosemund (Ber...